Article Figures & Data
Tables
- Table 1.
Characteristics of Patients (n = 932) and Visits (n = 2,103) Seen by 61 Participating Physicians
Patient characteristics Age (years) 65–74 625 (67.1) ≥75 307 (32.9) Female sex 591 (63.4) Race White 521 (55.9) Black 380 (40.8) Other* 31 (3.3) Index conditions Hypertension 794 (85.2) Hyperlipidemia 618 (66.3) Osteoarthritis 506 (54.3) Gastroesophageal reflux 363 (38.9) Diabetes mellitus 334 (35.8) Depression 315 (33.8) Commonly prescribed PIMs† Cyclobenzaprine 45 (4.8) Meclizine 39 (4.2) Hydroxyzine 35 (3.8) Estrogens 33 (3.5) Clonazepam 29 (3.1) Paroxetine 29 (3.1) Diphenhydramine 28 (3.0) Lorazepam 26 (2.8) Amitriptyline 24 (2.6) Zolpidem 16 (1.7) Encounter characteristics Prescriptions per visit 0–4 283 (13.5) 5–9 774 (36.8) 10–14 690 (32.8) ≥15 356 (16.9) PIMs per visit 0 1357 (64.5) 1–3 712 (33.9) 4–6 33 (1.6) ≥7 1 (0.1) Physician characteristics Age (years), mean (SD) 36.1 (10.6) Female sex, n (%) 30 (49.9) Years since graduation, mean (SD) 9.7 (10.1) Position, n (%) Resident 38 (62.3) Fellow/Faculty 23 (37.7) Patient panel characteristics* (%), mean (SD) Patients ≥75 years old 34.1 (17.6) Minority patients (black and others) 46.0 (24.7) Item responses Perceived importance/confidence for deprescribing, mean (SD) (1 = not at all, 5 = very much) How important is it for you to deprescribe for patients 65 years or older in outpatient settings? 4.4 (0.7) How confident are you in deprescribing for patients 65 years or older in outpatient settings? 3.7 (1.0) Importance of 9 triggers for deprescribing,† mean (SD) (1 = not important, 5 = very important) Symptoms possibly related to medication 4.8 (0.5) Cognitive impairment 4.6 (0.7) Limited life expectancy 4.6 (0.7) Wishes of patient/family 4.5 (0.8) Functional dependency 4.4 (0.7) Number of medications 4.4 (0.8) Older age 4.2 (0.9) Budgetary considerations 4.2 (0.9) Number of chronic conditions 4.1 (0.9) Importance of 6 barriers for deprescribing,‡ mean (SD) (1 = not important, 5 = very important) Patients belief that drugs might help 3.6 (0.9) Lack of time 3.5 (1.1) Medications started by other doctor 3.5 (1.0) Lack of benefit/risk information about deprescribing 2.9 (1.2) Lack of experience 2.6 (1.4) Patients belief that you are giving up on them 2.6 (1.2) - Table 3.
Multivariable Regression: Factors Associated with Physicians' Numbers of Prescriptions and Potentially Inappropriate Medication Orders
Variables Prescriptions PIM Orders Lack of benefit/risk information about deprescribing* −0.40 (0.16)† −0.06 (0.03)† Number of medications* −0.67 (0.24)† −0.07 (0.04) Proportion of minority patients −3.72 (0.81)† −0.34 (0.14)† Proportion of patients aged ≥75 −2.92 (1.13)† −0.45 (0.20)† Use of the Beers List‡ −0.17 (0.08) Intercept 16.31 (1.32)† 1.40 (0.24)† Adjusted R2 (AIC) 0.3939 (228) 0.2062 (12.4) Data are β (standard error). All variables included in the fitted models are reported in this table.
↵* The importance of triggers/barriers were assessed using 5-point Likert scales ranging from 1(Not important) to 5(very important).
↵† P < .05.
↵‡ Reference group includes those physicians who did not use the Beers List.
AIC, Akaike information criterion; PIM, potentially inappropriate medication.